Clinical Trial Update: A Randomized Controlled Trial of SP-01 (Granisetron Transdermal Delivery System) in Chemotherapy-induced Nausea and Vomiting [Phase 3]

View source ↗

Summary

Phase 3 randomized trial of SP-01 Granisetron Transdermal Delivery System for chemotherapy-induced nausea and vomiting has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• SP-01 (granisetron transdermal delivery system)

Snippet

Sponsor: Solasia Pharma K.K. | Conditions: Chemotherapy-induced Nausea and Vomiting | Phase 3 | Status: COMPLETED